Alternative Cancer Treatments for Stage I, II and III Cancer Patients
Links shared publicly online about this topic.
- 843total visits
Alternative Cancer Treatments for Stage I, II and III Cancer Patients
View full resource at cancertutor.com
Most Recently Shared on September 27, 2010 at 1:43 pm By:
Alternative Cancer Treatments for Stage I, II and III Cancer Patients http://j.mp/avJqCY
CLL patients receive Biothera's new combination therapy in Phase I/II clinical trial
news-medical.net — “Patients with earlier stage high-risk Chronic Lymphocytic Leukemia recently began receiving a new combination treatment in a Phase I/II clinical trial that researchers believe could result in a more effective therapy for this disease, Biothera announced today.” View full resource at news-medical.net
Most Recently Shared on March 15, 2011 at 12:32 pm By:
Lung Cancer News: CLL patients receive Biothera's new combination therapy in Phase I/II clinical trial: Patients... http://bit.ly/gx0817
Bayer To Present Early Clinical Data On Two Phase III Compounds In Company's Oncology Pipeline At ESMO 2010 - QualityPoint Technologies
qualitypointtech.net — “Bayer Schering Pharma AG, Germany, announced that data from Phase I and II studies evaluating two of the company's late-stage pipeline cancer treatments AlpharadinTM (radium-223 chloride) and regorafenib (BAY 73-4506) will be presented at the 35th European Society for Medical Oncology (ESMO) Congress, October 8-12, 2010, in Milan, Italy. Alpharadin is currently in a global Phase III clinical trial (ALSYMPCA) in patients with castration-resistant prostate cancer (CRPC) whose cancer has spread to ” View full resource at qualitypointtech.net
Most Recently Shared on October 9, 2010 at 2:12 pm By:
Bayer To Present Early Clinical Data On Two Phase III Compounds In Company's Oncology Pipeline At ESMO 2010: Baye... http://bit.ly/a0YLEy
Oncology Medical News about Carcinoma, Non-Small-Cell Lung
mdlinx.com — “Phase II proof-of-concept study of pazopanib monotherapy in treatment-naive patients with stage I/II resectable non-small-cell lung cancer” View full resource at mdlinx.com
Most Recently Shared on June 4, 2010 at 8:58 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Phase II proof-of-concept study of pazopanib monotherapy in treatment-naive patients with stage I/II rese... http://bit.ly/bhH1Hp #oncology
Advertisement
